Marshall Urist, MD;PhD
EVP, HEAD OF RESEARCH & INVESTMENTS, ROYALTY PHARMA MANAGEMENT, LLC
New York, New York, United States
Dr. Urist Joined Royalty Pharma in 2013. Previously, Dr. Urist was an executive director and the senior biotechnology analyst at Morgan Stanley. Dr. Urist has a BA, Phi Beta Kappa, from Johns Hopkins University, a PhD from Columbia University, and an MD from Columbia University.